These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20617415)

  • 1. Heparin and low-molecular weight heparins in thrombosis and beyond.
    Mousa SA
    Methods Mol Biol; 2010; 663():109-32. PubMed ID: 20617415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparins in thrombosis and cancer: emerging links.
    Mousa SA
    Cardiovasc Drug Rev; 2004; 22(2):121-34. PubMed ID: 15179449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotics in thrombosis and cancer.
    Mousa SA
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):283-91. PubMed ID: 15030287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin in thrombosis and cancer.
    Mousa SA
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():25-30. PubMed ID: 15085463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links.
    Mousa SA
    Semin Thromb Hemost; 2007 Jul; 33(5):524-33. PubMed ID: 17629850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparins and angiogenesis.
    Norrby K
    APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
    Mousa SA; Petersen LJ
    Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotics in thrombosis and cancer.
    Mousa SA
    Hamostaseologie; 2005 Nov; 25(4):380-6. PubMed ID: 16395488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosis.
    Fareed J; Ma Q; Florian M; Maddineni J; Iqbal O; Hoppensteadt DA; Bick RL
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():89-104. PubMed ID: 15085470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and low molecular weight heparin in thrombosis and beyond.
    Mousa SA
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosis.
    Kaiser B; Kirchmaier CM; Breddin HK; Fu K; Fareed J
    Semin Thromb Hemost; 1999; 25 Suppl 3():35-42. PubMed ID: 10549714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies on the biochemistry and pharmacology of low molecular weight heparins.
    Jeske W; Fareed J
    Semin Thromb Hemost; 1999; 25 Suppl 3():27-33. PubMed ID: 10549713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thrombotics in thrombosis and cancer.
    Mousa SA
    Future Oncol; 2005 Jun; 1(3):395-403. PubMed ID: 16556013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for the antithrombotic activity in man of low molecular weight heparins (LMWHs).
    Samama MM; Bara L; Gerotziafas GT
    Haemostasis; 1994; 24(2):105-17. PubMed ID: 7959358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-anticoagulant effects of unfractionated and low-molecular weight heparins.
    Walenga JM
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):759-60. PubMed ID: 17998892
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of low molecular weight heparins in animal models.
    Fareed J; Fu K; Yang LH; Hoppensteadt DA
    Semin Thromb Hemost; 1999; 25 Suppl 3():51-5. PubMed ID: 10549716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparins: are they different?
    Fareed J; Hoppensteadt D; Jeske W; Clarizio R; Walenga JM
    Can J Cardiol; 1998 Aug; 14 Suppl E():28E-34E. PubMed ID: 9779031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants in thrombosis and cancer: the missing link.
    Mousa SA
    Semin Thromb Hemost; 2002 Feb; 28(1):45-52. PubMed ID: 11885025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin.
    Young E; Wells P; Holloway S; Weitz J; Hirsh J
    Thromb Haemost; 1994 Mar; 71(3):300-4. PubMed ID: 8029793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.